Qiansui International Group Co Ltd
Change company Symbol lookup
Select an option...
QIAN Qiansui International Group Co Ltd
BV Brightview Holdings Inc
PFE Pfizer Inc
MP Mp Materials Corp
WFG West Fraser Timber Co Ltd
MDT Medtronic PLC
ATMR^ Altimar Acquisition Corp II
AEG Aegon NV
MGP MGM Growth Properties LLC
WRB W R Berkley Corp
Go


Based in China
Company profile

Qiansui International Group Co Ltd, formerly Ariel Clean Energy Inc, is a shell company. The Company is engaged in seeking new business opportunities with business entities for merger with or acquisition of a target business. The Company may seek a business opportunity with entities that have commenced operations, or entities wishing to utilize the public marketplace in order to raise additional capital to expand business development activities, to develop a new product or service, or for other corporate purposes. The Company may acquire assets and establish subsidiaries in various businesses or acquire existing businesses as subsidiaries. In implementing a structure for a particular business acquisition or opportunity, the Company may become a party to a merger, consolidation, reorganization, joint venture or licensing agreement with another corporation or entity. The Company may also acquire stock or assets of an existing business. The Company does not have a source of revenue.

Closing Price
$1.23
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.23
Day's Low
1.23
Volume
(Heavy Day)
Volume:
550

10-day average volume:
418
550

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of XL, VRM and ACAD

12:26 pm ET May 7, 2021 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / May 7, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

XL Fleet Corp. (NYSE:XL)

Class Period: October 2, 2020 - March 2, 2021

Lead Plaintiff Deadline: May 7, 2021

During the class period, XL Fleet Corp. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) XL Fleet's salespeople were pressured to inflate their sales pipelines to boost the Company's reported sales and backlog; (2) at least 18 of the 33 customers that XL featured were inactive and had not placed an order since 2019; (3) XL's technology had been materially overstated and offered only 5% to 10% of fleet savings; (4) XL lacks the supply chain and engineers to roll out new products on the announced timelines; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in XL: http://www.kleinstocklaw.com/pslra-1/xl-fleet-corp-loss-submission-form?id=15597&from=1

Vroom, Inc. (NASDAQ:VRM)

Class Period: June 9, 2020 - March 3, 2021

Lead Plaintiff Deadline: May 21, 2021

The VRM lawsuit alleges Vroom, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) Vroom had not demonstrated that it was able to control and scale growth in respect to its salesforce to meet the demand for its products; (2) as a result, the Company was forced to discount aged inventory to move through its retail channels or liquidated in its wholesale channels; (3) as a result, the ecommerce gross profit per unit was reasonably likely to decline; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in VRM: http://www.kleinstocklaw.com/pslra-1/vroom-inc-loss-submission-form?id=15597&from=1

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD)

Class Period: June 15, 2020 - April 4, 2021

Lead Plaintiff Deadline: June 18, 2021

The complaint alleges Acadia Pharmaceuticals Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the materials submitted in support of the pimavanserin sNDA contained statistical and design deficiencies; (ii) accordingly, the pimavanserin sNDA lacked the evidentiary support that the Company had led investors to believe it possessed; (iii) the FDA was unlikely to approve the pimavanserin sNDA in its present form; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in ACAD: http://www.kleinstocklaw.com/pslra-1/acadia-pharmaceuticals-inc-loss-submission-form?id=15597&from=1

Image: https://www.accesswire.com/users/newswire/images/645694/Klein-newsfile-logo220x220.png

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.

Empire State Building

350 Fifth Avenue

59th Floor

New York, NY 10118

jk@kleinstocklaw.com

Telephone: (212) 616-4899

Fax: (347) 558-9665

www.kleinstocklaw.com

SOURCE: The Klein Law Firm

View source version on accesswire.com:

https://www.accesswire.com/645694/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-XL-VRM-and-ACAD

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.